These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 15781816

  • 1. Gray and white matter volume changes in early RRMS: a 2-year longitudinal study.
    Tiberio M, Chard DT, Altmann DR, Davies G, Griffin CM, Rashid W, Sastre-Garriga J, Thompson AJ, Miller DH.
    Neurology; 2005 Mar 22; 64(6):1001-7. PubMed ID: 15781816
    [Abstract] [Full Text] [Related]

  • 2. Brain atrophy in clinically early relapsing-remitting multiple sclerosis.
    Chard DT, Griffin CM, Parker GJ, Kapoor R, Thompson AJ, Miller DH.
    Brain; 2002 Feb 22; 125(Pt 2):327-37. PubMed ID: 11844733
    [Abstract] [Full Text] [Related]

  • 3. Gray matter atrophy is related to long-term disability in multiple sclerosis.
    Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, Miszkiel KA, Thompson AJ, Miller DH.
    Ann Neurol; 2008 Sep 22; 64(3):247-54. PubMed ID: 18570297
    [Abstract] [Full Text] [Related]

  • 4. Exploring the effect of glatiramer acetate on cerebral gray matter atrophy in multiple sclerosis.
    AbdelRazek MA, Tummala S, Khalid F, Tauhid S, Jalkh Y, Khalil S, Hurwitz S, Zurawski J, Bakshi R.
    J Neurol Sci; 2023 Jan 15; 444():120501. PubMed ID: 36481574
    [Abstract] [Full Text] [Related]

  • 5. Evidence for progressive gray matter loss in patients with relapsing-remitting MS.
    Valsasina P, Benedetti B, Rovaris M, Sormani MP, Comi G, Filippi M.
    Neurology; 2005 Oct 11; 65(7):1126-8. PubMed ID: 16217074
    [Abstract] [Full Text] [Related]

  • 6. Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing-remitting multiple sclerosis: A retrospective analysis.
    Fisher E, Nakamura K, Lee JC, You X, Sperling B, Rudick RA.
    Mult Scler; 2016 Apr 11; 22(5):668-76. PubMed ID: 26238463
    [Abstract] [Full Text] [Related]

  • 7. Brain atrophy and lesion load in a large population of patients with multiple sclerosis.
    Tedeschi G, Lavorgna L, Russo P, Prinster A, Dinacci D, Savettieri G, Quattrone A, Livrea P, Messina C, Reggio A, Bresciamorra V, Orefice G, Paciello M, Brunetti A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Patti F, Salemi G, Cammarata E, Simone IL, Salvatore M, Bonavita V, Alfano B.
    Neurology; 2005 Jul 26; 65(2):280-5. PubMed ID: 16043800
    [Abstract] [Full Text] [Related]

  • 8. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E, Lee JC, Nakamura K, Rudick RA.
    Ann Neurol; 2008 Sep 26; 64(3):255-65. PubMed ID: 18661561
    [Abstract] [Full Text] [Related]

  • 9. Grey and white matter atrophy in early clinical stages of primary progressive multiple sclerosis.
    Sastre-Garriga J, Ingle GT, Chard DT, Ramió-Torrentà L, Miller DH, Thompson AJ.
    Neuroimage; 2004 May 26; 22(1):353-9. PubMed ID: 15110026
    [Abstract] [Full Text] [Related]

  • 10. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
    Mühlau M, Buck D, Förschler A, Boucard CC, Arsic M, Schmidt P, Gaser C, Berthele A, Hoshi M, Jochim A, Kronsbein H, Zimmer C, Hemmer B, Ilg R.
    Mult Scler; 2013 Oct 26; 19(11):1485-92. PubMed ID: 23462349
    [Abstract] [Full Text] [Related]

  • 11. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
    Oreja-Guevara C, Rovaris M, Iannucci G, Valsasina P, Caputo D, Cavarretta R, Sormani MP, Ferrante P, Comi G, Filippi M.
    Arch Neurol; 2005 Apr 26; 62(4):578-84. PubMed ID: 15824256
    [Abstract] [Full Text] [Related]

  • 12. Interferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy.
    Zivadinov R, Locatelli L, Cookfair D, Srinivasaraghavan B, Bertolotto A, Ukmar M, Bratina A, Maggiore C, Bosco A, Grop A, Catalan M, Zorzon M.
    Mult Scler; 2007 May 26; 13(4):490-501. PubMed ID: 17463072
    [Abstract] [Full Text] [Related]

  • 13. Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.
    Boster A, Hreha S, Berger JR, Bao F, Penmesta R, Tselis A, Endress C, Zak I, Perumal J, Caon C, Vazquez J, Tyler KL, Racke MK, Millis S, Khan O.
    Arch Neurol; 2009 May 26; 66(5):593-9. PubMed ID: 19433659
    [Abstract] [Full Text] [Related]

  • 14. Spatiotemporal distribution pattern of white matter lesion volumes and their association with regional grey matter volume reductions in relapsing-remitting multiple sclerosis.
    Bendfeldt K, Blumhagen JO, Egger H, Loetscher P, Denier N, Kuster P, Traud S, Mueller-Lenke N, Naegelin Y, Gass A, Hirsch J, Kappos L, Nichols TE, Radue EW, Borgwardt SJ.
    Hum Brain Mapp; 2010 Oct 26; 31(10):1542-55. PubMed ID: 20108225
    [Abstract] [Full Text] [Related]

  • 15. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.
    Rudick RA, Lee JC, Nakamura K, Fisher E.
    J Neurol Sci; 2009 Jul 15; 282(1-2):106-11. PubMed ID: 19100997
    [Abstract] [Full Text] [Related]

  • 16. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis.
    Calabrese M, Rocca MA, Atzori M, Mattisi I, Favaretto A, Perini P, Gallo P, Filippi M.
    Ann Neurol; 2010 Mar 15; 67(3):376-83. PubMed ID: 20373349
    [Abstract] [Full Text] [Related]

  • 17. Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis.
    Chard DT, Griffin CM, Rashid W, Davies GR, Altmann DR, Kapoor R, Barker GJ, Thompson AJ, Miller DH.
    Mult Scler; 2004 Aug 15; 10(4):387-91. PubMed ID: 15327034
    [Abstract] [Full Text] [Related]

  • 18. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, Atzori M, Bernardi V, Barachino L, Rinaldi L, Perini P, Gallo P, Filippi M.
    Arch Neurol; 2009 Sep 15; 66(9):1144-50. PubMed ID: 19752305
    [Abstract] [Full Text] [Related]

  • 19. Multimodal MRI study on the relation between WM integrity and connected GM atrophy and its effect on disability in early multiple sclerosis.
    Weeda MM, van Nederpelt DR, Twisk JWR, Brouwer I, Kuijer JPA, van Dam M, Hulst HE, Killestein J, Barkhof F, Vrenken H, Pouwels PJW.
    J Neurol; 2024 Jan 15; 271(1):355-373. PubMed ID: 37716917
    [Abstract] [Full Text] [Related]

  • 20. Association of regional gray matter volume loss and progression of white matter lesions in multiple sclerosis - A longitudinal voxel-based morphometry study.
    Bendfeldt K, Kuster P, Traud S, Egger H, Winklhofer S, Mueller-Lenke N, Naegelin Y, Gass A, Kappos L, Matthews PM, Nichols TE, Radue EW, Borgwardt SJ.
    Neuroimage; 2009 Mar 01; 45(1):60-7. PubMed ID: 19013533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.